PAI
CDNA icon

Palo Alto Investors’s CareDx CDNA Stock Holding History

Palo Alto Investors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.23M Buy
531,870
+53,650
+11% +$1.02M 1.41% 20
2025
Q4 		$9.01M Buy
478,220
+162,016
+51% +$2.71M 1.25% 21
2025
Q3 		$4.6M Buy
+316,204
New +$4.51M 0.85% 25

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Palo Alto Investors's CDNA Position: Q1 2026 in Review

Palo Alto Investors increased its CareDx (CDNA) stake by 11% in Q1 2026, buying an estimated $1.02M and bringing the position to 531,870 shares worth $9.23M. The position accounts for 1.41% of the portfolio, ranked #20.

Palo Alto Investors first reported a position in CDNA in Q3 2025 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Palo Alto Investors held 531,870 shares of CareDx worth $9.23M as of Q1 2026.
  • Palo Alto Investors bought 53,650 CareDx shares in Q1 2026, an estimated $1.02M.
  • CareDx made up 1.41% of Palo Alto Investors's portfolio in Q1 2026, its #20 holding.
  • Palo Alto Investors first reported a position in CareDx in Q3 2025 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.